Adrienne Shade

Adrienne Shade serves as a procurement specialist within the U.S. Agency for International Development’s Bureau for Global Health, where she manages acquisitions critical to advancing international public health outcomes. Her work centers on securing technical services and research capabilities that support global health system strengthening, infectious disease control, and health supply chain resilience. She plays a pivotal role in executing strategic procurements aligned with USAID’s mission to deliver life-saving interventions in low-resource settings, primarily through performance-based contracts for scientific and technical assistance. Her portfolio focuses on high-impact, evidence-driven initiatives requiring specialized expertise in global health innovation and implementation science. Adrienne collaborates with a diverse array of contractors, including academic research institutions, global health NGOs, and biotechnology firms with demonstrated capacity in field-based health interventions. Her contracting patterns reflect a preference for partners with proven experience in low- and middle-income country contexts, particularly those capable of delivering integrated health system solutions under complex operational conditions. She fosters long-term vendor relationships built on technical rigor, adaptive management, and compliance with international development standards, ensuring that contractor performance aligns with USAID’s accountability and impact objectives. Adrienne’s procurement activity is entirely non-set-aside, with 100% of awards issued under full and open competition. While she does not prioritize socioeconomic set-asides such as 8(a), HUBZone, or SDVOSB programs, her approach emphasizes merit-based selection grounded in technical capability, past performance, and global health expertise. This reflects the Bureau’s need for specialized, scalable solutions that often exceed the capacity of small business vendors in this niche domain. Her primary procurement focus is on NAICS 541714—Research and Development in Biotechnology—encompassing diagnostic innovation, vaccine delivery systems, and molecular surveillance technologies. She routinely procures services related to pathogen characterization, clinical trial support, and health data analytics, requiring deep domain expertise in infectious disease biology and global health operations. Her technical acumen ensures that acquisitions directly enable evidence-based programming and scalable public health outcomes.